EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Prostaglandin Transporter and Dipeptidyl Peptidase-4 as New Pharmacological Targets in the Prevention of Acute Kidney Injury in Diabetes: An In Vitro Study

Beatriz Gallego-Tamayo iD, Ángela Santos-Aparicio iD, Julia Yago-Ibáñez iD, Laura Muñoz-Moreno, Francisco Javier Lucio-Cazaña iD, Ana B Fernández-Martínez iD

International Journal of Molecular Sciences · 2024

DOI: 10.3390/ijms25063345 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Beatriz Gallego-Tamayo und 5 weiteren Autor:innen. Beteiligte Einrichtung: Universidad de Alcalá, Departamento de Biología de Sistemas, Facultad de Medicina y Ciencias de la Salud, Campus Universitario, Crtra A2, Km. 33,600,…. Hauptthemen laut MEDLINE: Diabetes Mellitus, Acute Kidney Injury, Dipeptidyl-Peptidase IV Inhibitors. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIMHD NIH HHS, Community of Madrid, European Regional Development Fund "A way to make Europe".

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The probability of acute kidney injury (AKI) is higher in septic diabetic patients, which is associated with, among other factors, proximal tubular cell (PTC) injury induced by the hypoxic/hyperglycemic/inflammatory microenvironment that surrounds PTCs in these patients. Here, we exposed human PTCs (HK-2 cells) to 1% O2/25 mM glucose/inflammatory cytokines with the aim of studying the role of prostaglandin uptake transporter (PGT) and dipeptidyl peptidase-4 (DPP-4, a target of anti-hyperglycemic agents) as pharmacological targets to prevent AKI in septic diabetic patients. Our model reproduced two pathologically relevant mechanisms: (i) pro-inflammatory PTC activation, as demonstrated by the increased secretion of chemokines IL-8 and MCP-1 and the enhanced expression of DPP-4, intercellular leukocyte adhesion molecule-1 and cyclo-oxygenase-2 (COX-2), the latter resulting in a PGT-dependent increase in intracellular prostaglandin E2 (iPGE2); and (ii) epithelial monolayer injury and the consequent disturbance of paracellular permeability, which was related to cell detachment from collagen IV and the alteration of the cell cytoskeleton. Most of these changes were prevented by the antagonism of PGE2 receptors or the inhibition of COX-2, PGT or DPP-4, and further studies suggested that a COX-2/iPGE2/DPP-4 pathway mediates the pathogenic effects of the hypoxic/hyperglycemic/inflammatory conditions on PTCs. Therefore, inhibitors of PGT or DPP-4 ought to undergo testing as a novel therapeutic avenue to prevent proximal tubular damage in diabetic patients at risk of AKI.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes MellitusAcute Kidney InjuryDipeptidyl-Peptidase IV InhibitorsHumansCyclooxygenase 2Dipeptidyl-Peptidases and Tripeptidyl-PeptidasesProstaglandinsDipeptidyl Peptidase 4

Stichwörter der Autor:innen

acute kidney injurycyclo-oxygenase-2diabetes mellitusdipeptidyl peptidase-4prostaglandin E2prostaglandin transporterproximal tubular cellssepsis

Substanzen

Cyclooxygenase 2Dipeptidyl-Peptidases and Tripeptidyl-PeptidasesProstaglandinsDipeptidyl-Peptidase IV InhibitorsDipeptidyl Peptidase 4

Autor:innen und Institutionen

  • Universidad de Alcalá, Departamento de Biología de Sistemas, Facultad de Medicina y Ciencias de la Salud, Campus Universitario, Crtra A2, Km. 33,600, 28805 Alcalá de Henares, Spain.
  • Departamento de Biología, Universidad Autónoma de Madrid, 28049 Madrid, Spain.

ORCID-Profile: Beatriz Gallego-Tamayo, Ángela Santos-Aparicio, Julia Yago-Ibáñez, Francisco Javier Lucio-Cazaña, Ana B Fernández-Martínez

Förderung

  • NIMHD NIH HHS
  • Community of Madrid
  • European Regional Development Fund "A way to make Europe"
  • European Regional Development Fund «A way to make Europe»
  • Comunidad de Madrid I+D Biomedicine Activities Program 2022
  • Programa Operativo de Empleo Juvenil of the Comunidad Autónoma de Madrid

Zitieren

APA

Gallego-Tamayo, B., Santos-Aparicio, Á., Yago-Ibáñez, J., Muñoz-Moreno, L., Lucio-Cazaña, F. J., & Fernández-Martínez, A. B. (2024). Prostaglandin Transporter and Dipeptidyl Peptidase-4 as New Pharmacological Targets in the Prevention of Acute Kidney Injury in Diabetes: An In Vitro Study. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25063345

Vancouver

Gallego-Tamayo B, Santos-Aparicio Á, Yago-Ibáñez J, Muñoz-Moreno L, Lucio-Cazaña FJ, Fernández-Martínez AB. Prostaglandin Transporter and Dipeptidyl Peptidase-4 as New Pharmacological Targets in the Prevention of Acute Kidney Injury in Diabetes: An In Vitro Study. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25063345

BibTeX
@article{GallegoTamayo2024,
  author = {Gallego-Tamayo, Beatriz and Santos-Aparicio, Ángela and Yago-Ibáñez, Julia and Muñoz-Moreno, Laura and Lucio-Cazaña, Francisco Javier and Fernández-Martínez, Ana B},
  title = {Prostaglandin Transporter and Dipeptidyl Peptidase-4 as New Pharmacological Targets in the Prevention of Acute Kidney Injury in Diabetes: An In Vitro Study},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  doi = {10.3390/ijms25063345}
}
Kostenlos starten →